Last reviewed · How we verify

NCT05872334

The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery

Completed NA Last updated 24 May 2023
What this trial tests

NA trial testing Monofix in Colon Cancer in 120 participants. Completed in 5 April 2023.

Timeline
1 June 2021
Primary endpoint
30 September 2021
5 April 2023

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingsingle
Primary purposeprevention
Enrollment120
Start date1 June 2021
Primary completion30 September 2021
Estimated completion5 April 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

Adults 18 to 80, any sex, with Colon Cancer or Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to evaluate the safety and feasibility of mid-line fascial suturing using MONOFIX sutures in patients undergoing minimally invasive surgery for colorectal cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A prospective single-arm clinical trial to assess the safety and efficacy of monofilament polydioxanone barbed suture, MONOFIX<sup>®</sup>, on abdominal fascial closure.
    Pyo DH, Yun SH, Lee WY. · · 2024 · cited 1× · PMID 38877993 · DOI 10.1002/wjs.12247

Verify or expand the search:

Other recruiting trials for Colon Cancer

Currently open trials in the same condition.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05872334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing